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Abstract Imaging of the axilla typically occurs when pa-
tients present with axillary symptoms or newly diagnosed
breast cancer. An awareness of the axillary anatomy is
essential in order to generate an accurate differential diag-
nosis and guide patient management. The purpose of this
article is to review the indications for axillary imaging,
discuss the logistics of the scanning technique and percu-
taneous interventions, and present the imaging findings
and management of a variety of breast diseases involving
the axilla.
Teaching points
• Knowledge of normal axillary anatomy aids in determining
the aetiology of an axillary mass.
• The differential diagnosis of an axillary mass is broad and
can be subdivided by the location of the lesion.
• Imaging evaluation of the axilla usually entails diagnostic
mammography and targeted ultrasound.
• FNA or core needle biopsies are safe and accurate methods
for diagnosis and guiding management.
Keywords Mammography . Axilla . Targeted ultrasound
Introduction
Over the past several decades, coinciding with the
introduction of ultrasound, radiologists have increasing-
ly imaged the axilla in females presenting with axillary
symptoms and newly diagnosed breast cancer. In addi-
tion, image-guided axillary procedures have been em-
braced as a means to diagnose findings and guide
patient management. The purpose of this article is to
review the indications for axillary imaging, discuss the
logistics of the scanning technique and percutaneous
interventions, and present the imaging findings and
management of a variety of breast diseases involving
the axilla.
Basic anatomy
The axilla is composed of the axillary artery and vein, brachial
plexus, lymph nodes, fat, accessory breast tissue, skin and
subcutaneous glands. The anatomic boundaries are as follows:
superior: the clavicle, scapula and first rib; posterior:
subscapularis, teres major and latissimus dorsi muscles; ante-
rior: pectoralis major and minor muscles; medial: serratus
anterior and first four ribs; lateral: coracobrachialis and short
head of the biceps muscle. Generally, the breast imager is
primarily concerned with the lymph nodes located in the axilla
(Fig. 1). The lymph node-bearing area is divided into three
regions:
Level I: Lymph nodes lateral and inferior to the pectoralis
minor muscle
Level II: Lymph nodes beneath the pectoralis minor muscle
Level III: Lymph nodes deep and medial to the medial
border of the pectoralis minor muscle
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Scanning technique, logistics and image-guided
interventions
The standard imaging evaluation of a palpable axillary lump
for females over the age of 30 years in most of the USA
typically includes a mammogram with a “skin marker” over-
lying the palpable finding followed by a focussed ultrasound
of the area of concern. This may vary in different countries
and typically in the UK, for example, mammographic evalu-
ation begins at age 40 years. In younger patients, imaging
begins with ultrasound. For patients with a focal lump, scan-
ning is typically targeted over the area of concern; however, if
there is a suspicious finding, it is important to cover the entire
axillary region to evaluate for any associated findings. When
the study is being performed in a female newly diagnosedwith
breast cancer, imaging should be performed broadly to include
the entire extent of the axillary contents. Examination of level
I lymph nodes necessitates visualising the axillary vessels as
well as scanning the entire fatty contents from the margin of
the pectoralis muscles anteromedially to the latissimus dorsi
and teres major margin posterolaterally. The lateral thoracic
and thoracodorsal arteries and smaller branches will be seen
variably along each margin, respectively. Although node
groups typically follow these vessels, lymph nodes are fre-
quently found in isolation within the axillary fat. It is also very
important to scan inferiorly, down through the axillary tail,
because abnormal nodes are frequently found in this location
as well. Levels II and III are not routinely scanned, although
large level II nodes can sometimes be seen [1].
Axillary ultrasound should be performed using a high-
frequency (7.5–17-MHz) linear-array transducer. A lower fre-
quency (5–7.5-MHz) setting may be needed for larger patients
or for patients with a large axillary fat pad; however, the
spatial resolution will be compromised. The patient should
lie in a supine oblique position, with her hand above her head
with the arm abducted and externally rotated (“bathing beau-
ty” position). All findings should be documented in orthogo-
nal planes with and without calipers and a lesion’s largest
dimension should also be recorded. Some facilities employ
grey-scale and colour Doppler US or power Doppler US
during the study, especially when assessing lymph nodes.
When colour Doppler US is used, it is important to use low
wall filter settings and low velocity settings (higher pulse
repetition frequency) to detect abnormal blood flow. The
colour gain should be increased high enough to detect
Fig. 1 The axilla is composed of the axillary artery and vein, brachial
plexus, lymph nodes, fat, accessory breast tissue, skin and subcutaneous
glands. The lymph node-bearing area is divided into three regions: level I:
lymph nodes lateral and inferior to the pectoralis minor muscle; level II:
lymph nodes under the pectoralis minor muscle; level III: lymph nodes
deep and medial to the medial border of the pectoralis minor muscle
Table 1 Axillary findings
Benign Malignant
Skin and subcutaneous tissues Seborrheic keratosis, sebaceous cyst,
epidermoid inclusion cyst
Skin metastases, melanoma
Accessory breast tissue Fibroadenoma, pseudoangiomatous stromal
hyperplasia (PASH), fibrocystic change
Breast cancer





Primary breast malignancy, metastatic




Granulomatous disease, gold therapy (rheumatoid
arthritis treatment)
Ductal carcinoma in situ (DCIS),
metastatic disease [thyroid
(papillary), ovarian]
Post-operative findings Skin thickening, lymphoedema, post-operative
fluid collections/lymphocele, fat necrosis,
abscess, haematoma
Primary or metastatic recurrence
Neoplasms Granular cell tumour, schwannoma Primary breast cancer
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subtle flow without causing a colour noise artefact. When
evaluating lymph nodes, ultrasound is 94 % sensitive and
72 % specific in characterising nodes as suspicious or benign
based on size and morphologic features [2].
If the initial imaging evaluation of the axilla reveals
a suspicious finding, percutaneous procedures, such as
ultrasound-guided fine-needle aspiration (FNA) or
ultrasound-guided core biopsy, may be performed. At
Fig. 2 Sebaceous cyst or
epidermal inclusion cyst. a
Tangential view reveals that this
lesion is located within in the
skin. b Ultrasound confirms a
hypoechoic mass within the skin
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most institutions, FNA is currently the preferred ap-
proach as the procedure is usually diagnostic and po-
tential complications are minimal (bleeding, infection,
non-diagnostic sample). FNA is typically performed
using 22–25-gauge needles with aspirates sent to cy-
tology. In most cases, at least three passes are made,
especially if the cytologist is not on site during the
procedure. If lymphoma is of clinical concern, addi-
tional aspirates should be obtained for flow cytometry.
However, limitations do exist for FNA as it can be
operator dependent, requires access to reliable cytology
and carries a relatively high false-negative rate of 12–
23 % [3] . Most commonly performed for suspicious
lymphadenopathy, the confirmation of metastatic in-
volvement in a lymph node precludes sentinel lymph
node biopsy in females with newly diagnosed breast
cancer leading to full axillary node dissection. In one
study of 224 patients, the sensitivity of ultrasound-
guided FNA for suspicious, indeterminate and normal-
appearing axillary nodes was 93, 44 and 11 %, respec-
tively, with an overall sensitivity of 59 % and overall
specificity of 100 % [2]. The likelihood of a positive
FNA correlated directly with the size of the primary
breast malignancy, being 29 % for tumours <1 cm,
50 % for tumours 1–2 cm, 69 % for tumours 2–5 cm
and 100 % for tumours >5 cm [2]. Alternatively, per-
cutaneous core needle biopsy using 12–18 gauge
spring-loaded or vacuum-assisted devices can safely
be performed [4–7]. The risks of axillary core biopsy
are similar to other image-guided procedures, namely
bleeding and infection. However, given the presence of
axillary vessels and nerves coursing through the axilla,
a “no-throw” technique is preferred as this minimises
the risk of haematoma or unintended nerve damage. If
a spring-loaded device is used, this most commonly is
performed on masses that exceed the throw of the
device so that the needle does not pass into unaffected
axillary tissue, thereby minimising the risk of
unintended complications. In one study of 39 patients
with suspicious lymphadenopathy, axillary core biopsy
revealed 90 % sensitivity, 100 % specificity and 92 %
accuracy [8] without any clinically significant compli-
cations. By recognising that the nerves course along-
side the axillary vessels, the risk of bleeding and
untoward nerve injury can easily be avoided in almost
all cases. Although core biopsy may yield a benign
aetiology, there is conflicting evidence concerning
whether this approach is substantially better than
FNA as the upgrade rate on surgical excision ranges
from 0 to 36 % in several studies, possibly related to
the small cohort size and inherent sampling error [8].
Differential diagnosis of axillary findings
There are a wide variety of imaging findings that can be
seen while scanning the axilla. Ranging from skin lesions
to abnormal lymphadenopathy to posterior chest wall
masses, the astute radiologist must apply their anatomic
and medical knowledge to recommend the most appropri-
ate management. Findings typically fall into six catego-
ries: skin lesions, congenital and developmental anoma-
lies, infectious, inflammatory and metastatic lymphade-
nopathy, post-operative changes, benign neoplasms and
extra-axillary masses (Table 1). Each of these categories
is covered in greater detail below.
Skin lesion/glands
The most common skin lesion is seborrheic keratosis, a raised
benign skin lesion with a verrucoid appearance. Epidermal
inclusion cysts and sebaceous cysts (Fig. 2) are located at the
junction of the dermis and subcutaneous fat and present on
imaging as circumscribed masses often with a visible tract to
the skin surface [9]. Epidermal inclusion cysts may occur
anywhere but tend to be more common in the axilla and the
inframammary fold. In addition, antiperspirant can appear as
radiopaque densities overlying the axilla seen on mammo-
graphic imaging (Fig. 3).
Congenital developmental anomaly-accessory breast
tissue
Breast tissue develops from the mammary ridges that
extend from the base of the forelimb bud along the ventral
surface of the embryo to an area medial to the base of the
hind limb bud, which is the primitive inguinal region.
Typically, the milk line regresses, leaving the middle
portion of the upper third of the mammary ridge from
Fig. 3 Antiperspirant artefact: magnified view shows radiopaque
densities overlying the axilla
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which the breast is formed. Failure of involution of the
milk line results in accessory breast tissue, most common-
ly in the axilla, but it can occur anywhere from the axilla
to the inguinal region. Accessory breast tissue occurs in
2–6 % of women (Fig. 4) [9, 10] and can be appreciated
on mammography, ultrasound and MRI. When accessory
tissue occurs, both benign and malignant breast lesions
can be seen (i.e. cysts, fibroadenomas, PASH, breast
cancer).
Lymph nodes
Although the axilla is partially imaged on mammography,
axillary lymph nodes can often be seen. Classically, benign
axillary lymph nodes typically are smaller than 2 cm in
maximal size and have a hilar radiolucent notch. Increased
size and/or increased density of a node on mammography
raises concern for pathology. However, ultrasonography pro-
vides the best means to assess the axillary nodes given its
Fig. 4 Accessory breast tissue
with fibroadenoma: a BB placed
on the skin in the area of concern
to the patient. MLO views show
hetereogeneously dense 4 cm
asymmetry of similar density and
morphology to breast tissue. b
Targeted sonographic evaluation
of the right axilla in the area of
concern demonstrates
fibroglandular breast tissue and a
hypoechoic 8-mm solid mass.
Biopsy of the nodule using a no-
throw vacuum-assisted biopsy
device revealed fibroadenoma
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relatively sensitive and highly specific capabilities. A normal
or benign-appearing axillary lymph node should have an
oval or lobulated shape and a smooth, well-defined
margin. The lobulated shape is because of concurrent
constrictions and bulges of both the cortex and fatty
hilum. The cortex should be slightly hypoechoic and
uniformly thin, measuring 3 mm or less (Fig. 5). Nodes
that meet this description have a very high negative
predictive value for excluding metastases [11]. The
echogenic hilum should constitute the majority of the
node. Arterial flow in the hilum can be demonstrated
with colour Doppler imaging. Morphologic criteria, such
as cortical thickening, hilar effacement and non-hilar
cortical blood flow, are more important than size criteria
in the identification of metastases. Characteristics of
lymph nodes that are concerning for malignancy besides
overall size include round shape, absence of the fatty
hilum, and increased concentric or focal cortical thick-
ness greater than 3 mm, all being predictors of malig-
nancy (Fig. 6) [12–16].
A focal cortical bulge (Fig. 7) or thickening is con-
sidered the earliest detectable morphologic change in
the presence of metastasis, but this criterion is difficult
to apply and has a low positive predictive value be-
cause it is non-specific. This finding is therefore con-
sidered indeterminate. A true abnormal cortical bulge is
seen as focal thickening of the cortex that does not
follow the margin of the echogenic hilum and should
be distinctly hypoechoic, and this sign is more accurate
if associated with another finding such as the presence
of cortical in addition to hilar blood flow. Diffuse
cortical thickening can also be seen with metastasis,
but this finding is even more non-specific, more often
being associated with a reactive node. Eccentric cortical
thickening is more suspicious than diffuse thickening,
but both are non-specific and concerning enough to
warrant intervention in most cases (Fig. 8). Findings
seen in cases with more advanced nodal involvement,
such as effacement of the fatty hilum or a rounded
hypoechoic mass, have a higher positive predictive
value in patients with invasive breast cancer. Replace-
ment of the entire node or a portion of the node by an
ill-defined mass is highly suspicious for malignant in-
volvement. Occasionally, nodal microcalcifications can
be seen on imaging (Fig. 7).
Contrast-enhanced ultrasonography has been used
with some success to visualise enhancing abnormal
nodes after periareolar injection of microbubbles. Server
et al. in their study showed that sentinel lymph node
can be successfully identified and biopsied using
microbubble contrast-enhanced ultrasound, thereby
avoiding surgical biopsy in some patients [17].
Ultrasound and axillary core biopsy enable adequate
pretreatment staging in patients with breast cancer and
has a positive impact on their management [18, 19].
The benefit of pre-operative identification of axillary
metastases is that it allows the surgeon to proceed
directly to full axillary lymph node dissection and to
avoid an unnecessary sentinel lymph node biopsy,
Fig. 5 Normal lymph node: On ultrasound, lymph nodes typically
are smooth, gently lobulated ovals with a hypoechoic cortex
measuring less than 3 mm in thickness with a central echogenic
hilum
Fig. 6 Abnormal lymph nodes: characteristics concerning for
malignancy: a absence of the fatty hilum and b increased focal cortical
thickness greater than 3 mm with colour Doppler US that shows
hyperaemic blood flow in the hilum and central cortex or abnormal
(non-hilar cortical) blood flow
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thereby avoiding a second surgical procedure involving
the axillary nodes. Houssami et al. in their meta-
analysis found that axillary ultrasound-guided needle
biopsy (UNB) had better utility in females with aver-
age or higher underlying risk of nodal metastases [20]
and found that a median proportion of 18.4 % (inter-
quartile range = 13.3 %–27.4 %) from 7,097 patients
can be effectively triaged to axillary treatment and
avoid sentinel node biopsy (SNB). However, the
changing algorithm of axillary surgical treatment means
that ultrasound-guided FNA will have relatively less
utility where surgeons omit axillary lymph node dis-
section (ALND) for minimal nodal metastatic disease.
Research that allows enhanced application of ultra-
sound and UNB to specifically identify and biopsy
sentinel nodes and to discriminate between patients
with minimal versus advanced nodal metastatic in-
volvement is likely to have the most impact on future
management of the axilla in patients newly diagnosed
with breast cancer [21].
Recently, the field of breast cancer surgery has seen
a dramatic shift with the results of the American
College of Surgeons Oncology Group Z0011 trial
[22]. This study, which randomly assigned patients
with sentinel lymph node (SLN)-positive breast cancer
to SNB and (ALND) or to SNB alone, reported that
ALND was not associated with any survival benefit
and that both groups had an extremely low regional
recurrence rate (0.9 % for SNB alone and 0.5 % for
ALND). This was despite the fact that 27.3 % of the
patients who received ALND had additional positive
non-sentinel lymph nodes. This study confirmed what
many surgical oncologists had suspected: that ALND
provided minimal benefit while exposing a substantial
number of patients to long-term morbidity, specifically
lymphoedema. Therefore, there was great interest in
shifting away from routine ALND for patients with
SLN-positive disease, instead reserving this operation
for patients who did not meet the Z0011 criteria (i.e.
patients undergoing neoadjuvant chemotherapy, pa-
tients with palpable nodes, patients having mastectomy
or patients with more than three involved nodes). With
the results of Z0011, there has been some shift in the
approach to staging the axilla. Some surgeons have
Fig. 7 A 47-year-old female with
a palpable left breast lump. a Left
MLO view with magnified image
of the left axilla demonstrates a
1.4×1-cm lymph node with
eccentric cortical thickening and
cortical calcifications. b
Transverse image of left axillary
lymph node confirms echogenic
foci within the thickened cortex
suspicious for malignancy. FNA
was performed with aspirates sent
for routine cytology and flow
cytometry. Final diagnosis:
metastatic carcinoma
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advocated to no longer obtain axillary ultrasound and
fine-needle aspiration (FNA) biopsy of suspicious
nodes because this practice identifies women with
“clinically evident” disease who, in the absence of
Fig. 8 A 54-year-old female with remote history of right breast cancer
and a left knee sarcoma now for screening. aMLO view demonstrates a
focally thickened non-enlarged left axillary lymph node. b Ultrasound
confirms a 1.4-cm lymph node with focal cortical thickening of 6 mm and
(c) internal vascular flow. FNA was performed for diagnosis. Aspirates
were sent for routine cytology and flow cytometry. Final diagnosis:
reactive lymph node
Fig. 9 A 55-year-old African American female for screening. a MLO
views of the breasts demonstrate a dense enlarged right axillary lymph
node and several abnormal-appearing intramammary lymph nodes. Right
axillary ultrasound confirms a large fatty replaced lymph node with non-
hilar internal vascular flow. This is highly suspicious for malignancy in a
patient with breast cancer; however this patient had a negative
mammogram and so an ultrasound-guided core biopsy was performed
for diagnosis. Final diagnosis: sarcoidosis
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the ultrasound, would have been “SLN positive” and
thus eligible for avoidance of the ALND. However, a
point to remember is that pre-operative ultrasound of
the axilla is still an extremely useful staging test as
nodal disease identified by ultrasound and FNA biopsy
is strongly correlated with tumour burden and the
number of involved nodes [23, 24].
Additionally abnormal appearing lymph nodes may be
seen related to both benign (Figs. 8 and 9) and neoplastic
processes (Figs. 6 and 7). In general, the differential
diagnosis for an enlarged axillary lymph node includes
reactive hyperplasia, HIV/immunocompromised state,
sarcoidosis or other granulomatous diseases, lymphoma/
leukaemia and metastatic disease (most commonly breast
cancer, lung cancer, ovarian cancer, gastric cancer or
melanoma). Calcifications involving lymph nodes within
the axilla can be seen because of either benign or malig-
nant causes. The differential diagnosis for calcified
lymph nodes includes prior granulomatous infection,
gold therapy in patients with rheumatoid arthritis
(Fig. 10), collagen vascular disease, and metastasis from
breast, thyroid or ovarian cancer. However, if high-
density particles are seen in the axilla, the first step is
to confirm that they are indeed located within a lymph
node and not related to antiperspirant on the skin sur-
face. This can readily be accomplished by recalling the
patient for a repeat MLO view after cleaning the axilla to
show that the densities are no longer present on the
image.
Post-operative axilla
Following axillary surgery, an array of findings can be
seen in the axilla. The most common findings include
skin and trabecular thickening (Fig. 11), post-operative
fluid collections/lymphoceles (Fig. 12), fat necrosis and
recurrence.
Benign neoplasms
There are several rare benign neoplasms that can occur
in the axilla, which also can mimic breast cancer in the
axillary tail of Spence. These tumours are most frequent-
ly are neural in origin and asymptomatic. Therefore, they
are most commonly encountered on screening mammog-
raphy. As these tumours are almost always benign, per-
cutaneous biopsy to confirm a benign entity is sufficient
and most often surgery is avoided.
Granular cell tumour (GCT) GCT is a rare neoplasm of
neural origin arising from perineural cells, accounting
for less than 1 % of breast lesions and more commonly
seen in African American women. Clinically, GCTs
manifest as firm, palpable masses and average 1 to
2 cm in size. Histologically, they arise from the
intralobular breast stroma and tend to form cords that
extend into adjacent normal breast parenchyma, a char-
acterist ic that simulates the growth pattern of
Fig. 10 A 56-year-old female treated with gold therapy for rheumatoid
arthritis. RightMLO (magnified image) of two right axillary lymph nodes
reveals fine punctate radiopaque densities secondary to previous gold
therapy for rheumatoid arthritis
Fig. 11 A 66-year-old female, 7 months out from lumpectomy, sentinel
lymph node biopsy and radiation therapy, presents for first post-treatment
mammogram. Diffuse left breast skin and trabecular thickening
accompanied by post-surgical distortion in the breast and axilla are
visible. Final diagnosis: Expected post-treatment changes following
breast cancer diagnosis
Insights Imaging (2015) 6:217–229 225
infiltrating carcinoma [25–27]. On mammography,
granular cell tumour of the breast is difficult to distin-
guish from carcinoma and may have irregular or
spiculated margins. On ultrasound it may be solid
hypoechoic with irregular margins (Fig. 13). GCTs are
usually benign neoplasms [28]. Despite the fact that
most cases occur in pre-menopausal women, GCTs
have been shown to be non-dependent on oestrogen
and progesterone [25]. The most widely accepted the-
ory supports a Schwann cell origin because of similar-
ities in ultrastructural features and the positivity of the
tumour for the S-100 protein, which is found in pe-
ripheral nerves. Diagnosis is confirmed by special
staining for S-100 protein, NSE and CEA [28]. Less
than 1 % of all GCTs, including mammary lesions, are
malignant. Malignant GCTs are considered high-grade
sarcomas with a high rate of metastasis and short
survival. Features suggestive of malignancy include
large size (>4 cm), increased mitotic rate (>2 mitosis/
10 high-power fields at × 200 magnification), rapid
growth, local invasion, and variation in cell size and
shape. The main histological element that distinguishes
GCTs from more ominous lesions is the presence of a
granular cytoplasm. Current treatment is wide surgical
excision. To date, there is no role for radiation or
chemotherapy [26, 28]. Local recurrence has been re-
ported after incomplete excision as late as 10 years
following removal, especially when the margins are
irregular or inadequate. GCTs pose a real diagnostic
challenge for physicians. Pre-operative diagnosis with
core needle biopsy is important because treatment is
with wide surgical excision rather than mastectomy
given the infiltrative pattern of growth [27].
Schwannoma There are scattered case reports in the
literature citing examples of breast schwannomas [29].
Schwannomas arise from Schwann cells of the periph-
eral nerve sheath. The most common locations include
the head, neck and extensor surfaces of the extremities.
Intramammary schwannomas account for only 2.6 % of
schwannomas. Mammographically, schwannomas are
most commonly described as a well-defined round or
oval mass, but sometimes may be ill defined (Fig. 14).
Sonographically, more variation in appearance has been
reported; however, it is most commonly described as a
solid hypoechoic well-defined mass with variable posterior
acoustic enhancement [29]. Microscopically, classic
schwannoma is an encapsulated neoplasm having two compo-
nents known as Antoni A and B tissue, in variable proportions.
Antoni A tissue is cellular and consists of monomorphic
spindle-shaped Schwann cells, with a poorly defined eosino-
philic cytoplasm and pointed basophilic nuclei, set in a variable
collagenous stroma [30]. These cells commonly show nuclear
palisading and parallel arrays of such palisades with intervening
eosinophilic cell cytoplasm (processes) are known as Verocay
bodies [31]. Breast schwannomas show no definite worrisome
mammographic or ultrasonographic features, and diagnosis on
imaging alone is not possible. A diagnosis of schwannoma of
the breast may be suggested on core needle biopsy if there is a
cytologically bland spindle cell lesion with areas of palisading
and lack of epithelial elements, especially if the cells
show immunostaining for S-100 protein [31]. However,
Fig. 12 A 80-year-old female with a history of sarcoidosis presenting
with a left axillary mass 1 year following axillary surgery of a benign
node. a MLO view and (b) ultrasound of the left axilla demonstrates a
4.1×2.7×3.5-cm well-circumscribed predominantly anechoic structure
with internal debris consistent with a complicated cyst. Aspiration was
performed for symptomatic relief. Final diagnosis: lymphocele of the left
breast demonstrates extensive skin and trabecular thickening and a well-
circumscribed left axillary mass
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distinction from other spindle cell lesions such as metaplastic
carcinomas, fibroepithelial lesions with minor epithelial com-
ponents, fibromatosis and myofibroblastoma, among others,
is challenging and most result in surgical excision [31, 32].
Extra-axillary lesions
The axilla also includes muscles and bones of the shoul-
der and upper rib cage. Therefore, recognising that an
axillary mass is within or beneath the muscle is essen-
tial in forming an appropriate differential diagnosis.
Although extra-axillary lesions are rare, benign and
malignant muscular neoplasms may be encountered
(Fig. 15). Intramuscular myxoma is a benign neoplasm
arising from fibroblasts, which produce excessive muco-
polysaccharide, accounting for their complex appearance
on US and heterogeneous signal on MR imaging. Most
commonly involving the heart, they can occur at other
sites including subcutaneous tissue, aponeurotic tissue,
bone, the genitourinary system and skin. They can be
associated with fibrous dysplasia (Mazabraud’s syn-
drome). On imaging, intramuscular myxoma typically
presents as a slowly enlarging mass that is often com-
plex on US and most of ten demonst rates T1
hypointensity, T2 hyperintensity, a T1 perilesional fat
rind, and rim and internal enhancement on MR. As
these lesions may be indistinguishable from myxoid
liposarcoma on imaging; biopsy is essential for diagno-
sis [33].
Fig. 14 A 64-year-old asymptomatic female presented for a screening
mammogram. MLO view of the left breast shows an 8-mm well-defined
ovoid mass in the left upper outer quadrant (arrow). Final diagnosis:
schwannoma
Fig. 13 A 50-year-old female with focal 1-cm asymmetry in the left
axilla region. aMLOviews demonstrate left axillary irregular asymmetry,
which persisted on spot compression. b Ultrasound of the left axilla
demonstrated a 12-mm irregular hypoechoic hypovascular mass in the
left axilla. Ultrasound-guided core needle biopsy was performed. Final
diagnosis: granular cell tumour
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Conclusions
Knowledge of the normal axillary anatomy aids in determining
the underlying aetiology of an axillary mass. The differential
diagnosis of an axillary mass is broad, including skin lesions,
infections, haematoma, lymphadenopathy (hyperplastic, in-
flammatory, neoplastic or metastatic), accessory breast tissue,
fibroadenoma, fibrocystic change, post-operative fluid collec-
tions, primary breast cancer and intramuscular neoplasms. For
most cases, imaging evaluation entails diagnostic mammogra-
phy and targeted ultrasound. If intervention is warranted, FNA
or core needle biopsies are safe and accurate methods for
diagnosis and for guiding the management of an axillary mass.
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